Describe Anticholinergic Premedication in detail.
Definition & Uses
Anticholinergic (antimuscarinic) drugs — chiefly atropine and glycopyrrolate (and hyoscine) — are used in anaesthesia to reduce airway secretions (antisialagogue), block vagally-mediated bradycardia (from drugs such as suxamethonium or from airway/surgical stimulation), and as an adjunct with neostigmine during reversal of neuromuscular blockade (to prevent its muscarinic bradycardia).
| Feature | Atropine | Glycopyrrolate |
|---|---|---|
| Onset/heart rate | Fast; marked tachycardia | Slower; less tachycardia |
| CNS (crosses BBB) | Yes (can cause delirium) | No (quaternary) — no central effects |
| Antisialagogue | Good | More potent, longer |
| Placenta | Crosses | Minimal crossing |
CLINICAL PEARL
Glycopyrrolate is a quaternary amine that does not cross the blood–brain barrier or placenta well, so it lacks central (delirium) effects and is preferred as an antisialagogue and with neostigmine; atropine acts faster on the heart and is the drug for acute bradycardia.
Cautions
Anticholinergics cause tachycardia (caution in ischaemic heart disease), dry mouth, blurred vision, urinary retention, and — with atropine/hyoscine — central anticholinergic effects (confusion, especially in the elderly). They are used cautiously in glaucoma and the elderly.
Physostigmine & Central Anticholinergic Syndrome
Because atropine and hyoscine cross the blood–brain barrier, they can occasionally cause a central anticholinergic syndrome — confusion, restlessness or excessive sedation, particularly in the elderly — which can be reversed by physostigmine, a tertiary anticholinesterase that also crosses into the brain. Glycopyrrolate, being a quaternary compound that does not cross the barrier, avoids this problem, which is one of the reasons it is often preferred when an antisialagogue or an antimuscarinic partner for neostigmine is required.
CLINICAL PEARL
Choose by the job: atropine for acute vagal bradycardia (fast, but crosses into the brain), glycopyrrolate as the antisialagogue and neostigmine partner (potent, longer, no central or placental effects).
Glycopyrrolate does not cross the blood-brain barrier.
KEY POINT
Key points TO remember
- Antimuscarinics (atropine, glycopyrrolate): reduce secretions, block vagal bradycardia, adjunct to neostigmine.
- Atropine: fast, marked tachycardia, crosses BBB (delirium) — drug for acute bradycardia.
- Glycopyrrolate: quaternary — no central effects, potent antisialagogue, minimal placental transfer.
- Cautions: tachycardia (IHD), dry mouth, retention, confusion (elderly), glaucoma.
EXAM TIP
Sources: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.
All questions in Preoperative Assessment & Premedication
- Q1Describe Preoperative Assessment in detail. ★
- Q2Describe ASA Physical Status Classification in detail. ★
- Q3Describe Preoperative Fasting & Aspiration Prophylaxis in detail. ★
- Q4Describe Premedication in detail. ★
- Q5Describe Anaesthesia in Common Coexisting Diseases in detail. ★
- SN1Write a short note on Mallampati Classification. ★
- SN2Rapid Sequence Induction ★
- SN3Write a short note on Mendelson’s Syndrome. ★
- SN4Describe Anticholinergic Premedication in detail.
- SN5Describe Pharmacological Aspiration Prophylaxis in detail.
- SN6Describe Functional Capacity & METs in detail.
- SN7Describe Informed Consent for Anaesthesia in detail.